 |
|
February 16, 2009 | |
MESSAGE FROM THE DIRECTOR– Impact of the Stimulus Package on Cancer ResearchI am sure that you noticed the surprising finish to the federal stimulus bill in which Arlen Specter achieved his long-standing goal of increasing funding to the NIH. This will not be a one time event, and could well be transformational. The NIH will receive an additional $10B and this will reset the annual appropriation from $29B to $39B. As Senator Specter stated in a recent New York Times article: "I think it's scandalous that we haven't done more to cure cancer," Mr. Specter said. The balance has tipped in terms of the priorities stated in the bill. Cancer and stem cell research will be prioritized. What does this mean to you and to the Cancer Center: As information comes out about the format of grants for any and all new applications, we will keep you informed. But the word on the street is that within 60 days, there will be an RFA released for a short application with a few years duration (2-3), with a defined endpoint, not so speculative that it will fail or still be a concept in 3 years. This means a commercializable discovery, drug, or insight into cancer cause or treatment. Finally, the cancer center administration will prioritize support to all investigators who respond to this new grant opportunity. Please call or email the Cancer Center if you need our help or support developing a grant idea, or need resources to help pursue a project. We will set aside other projects for this purpose. Stan Gerson, MD FUNDING OPPORTUNITY– AACR Gertrude B. Elion Cancer Research AwardThe AACR Gertrude B. Elion Cancer Research Award is open to tenure-track scientists at the level of Assistant Professor, who completed postdoctoral studies or clinical fellowships no more than five years prior to the start of the grant term. It provides a one-year grant of $50,000 for salary and benefits, laboratory supplies, and limited travel for the grant recipient. Projects may focus on research in cancer etiology, diagnosis, treatment, or prevention (basic, translational, or clinical cancer research). The recipient of the 2009 Award must attend the 2009 AACR Annual Meeting to accept the award, and is required to give a presentation of his or her research in a minisymposium at the 2010 AACR Annual Meeting. Deadline: February 27 For more information, please click here. FUNDING OPPORTUNITY– American Cancer Society IRG AwardsThe Case CCC is accepting applications for American Cancer Society (ACS) IRG pilot funding for cancer-related research in basic, clinical, prevention & control, behavioral, health services and epidemiology. These pilot project grants are intended to support independent, self-directed investigators early in their careers (usually assistant professor or equivalent). Applicants for the pilot project grants should be within six years of their first independent research or faculty appointment and eligible to apply for independent national competitive research grants, but may not currently hold such a grant. Recipients of IRG pilot project grants must be, at the time of the application, citizens or noncitizen nationals of the United States or its possessions and territories, or must have been lawfully admitted to the United States for permanent residence at the time of application. Application Deadline: April 6 Instructions, frequently asked questions, and applications available at http://cancer.case.edu. Contact Terri Daso, Cancer Center Administration, 844-7252, tld6@case.edu for more information. FUNDING OPPORTUNITY– Choose Ohio First Scholarship and Tomas & Evelyn James Fellowship in Bioinformatics, Computational Biology and Medical InformaticsThe primary objective of the Choose Ohio First Scholarship (COF) Program is to support increased higher education participation and success of Ohio students in bioinformatics, computational biology and medical informatics, through the development and implementation of innovative curricular and programs, and in so doing, to advance the economic growth of the state. Bioinformatics, computational biology, imaging, clinical and translational informatics, cancer informatics are commonly cast as sub-domains within Biomedical Informatics, the broad discipline concerned with the study and application of computer science, information science, informatics, cognitive science and human-computer interaction in the practice of biological research, biomedical science, medicine and healthcare. James-COF scholars must be a resident of Ohio, with a minimum GPA of 3.0. They should have a background compatible with academic excellence and leadership development in Biomedical Informatics. Each COF scholar is required to find a faculty mentor who will be responsible for the direction of program of study and supervision of appropriate projects. In addition to weekly meetings with their respective faculty mentors, James-COF scholars will meet at least once a semester collectively to share their experiences and report progress. All scholars are required to be on campus during summer 2009 for research under the direction of their faculty mentor. Scholars are also expected to participate in Ohio Consortium for Bioinformatics (OCBIO) activities, especially its annual conference series OCCBIO09, which will take place on the Case campus from June 15- 17, 2009. Deadline: February 20 For details, please click here. FUNDING OPPORTUNITY– ACS Cancer Research FellowshipACS is currently accepting applications for Cancer Research Fellowships. The purpose of these fellowships is to strengthen the field of cancer research by encouraging outstanding clinicians and scientists to pursue careers in oncology and academic medicine and to engage in basic or clinical cancer research upon completion of their specialty training. The fellowship in not intended to support PhD candidates already on a research track. These awards are intended for MDs, DOs, DDSs, PhDs in Nursing and others not already on a research track. PhDs are ineligible. Candidates must be nominated by a sponsor or advisor who is actively engaged in cancer related research. Application Deadline: March 18 For more information, please click here. FUNDING OPPORTUNITY– Association for International Cancer Research (AICR)AICR awards project grants of between one and three years to support fundamental and translational research into the causes, mechanisms, diagnosis, treatment and prevention of cancer. We will consider proposals in which a mixture of basic and clinical research is proposed. However, completely clinical applications, such as intervention studies, clinical trials or health care delivery research and many substantially clinical applications are beyond the remit of AICR. Before submitting applications of a clinical or semi-clinical nature, potential applicants are strongly encouraged to seek our advice by e-mailing a brief description of the proposed project to our Scientific Co-ordinator (matfield@aicr.org.uk). Applications will be accepted April 1-24. For details, please click here. |
EVENTS**All events are open to anyone interested in attending February 16Hematology/Oncology Research In Progress Seminar cancelled February 17Taussig Cancer Institute Core Curriculum Series February 18Grand Rounds Genetics/ Epidemiology & Biostatistics Seminar Genetics Special Seminar Developmental Therapeutics Program (DTP) Meeting February 19Aging-Cancer Research Seminar cancelled Taussig Cancer Institute Core Curriculum Series February 20Hematology/ Oncology Fellows Seminar Taussig Cancer Institute Grand Rounds Cancer Center Seminar Series/ Blood Club Genomics Medicine Institute Seminar Series more MARK YOUR CALENDARS:UPCOMING CANCER CENTER SYMPOSIUMSCase CCC Scientific Series Emerging Trends in Cancer Immunotherapy Family-Centered Care Signaling in Cancer Ohio Collaborative Conference on Bioinformatics (OCCBIO) Annual Breast Cancer Update: Highlights of the National Meetings Case CCC Scientific Retreat 2009 **For more information on these symposiums, please contact Christine Rhoads. UPCOMING OUTSIDE SEMINARS2nd Annual Biospecimen Research Network (BRN) Symposium: Advancing Cancer Research Through Biospecimen Science Second Annual David C. Hohn, MD Health Policy Lecture |
NCI CANCER BULLETINNote from Dr. Gerson: News Commentary FUNDING OPPORTUNITY– DOD Neurofibromatosis Research Program (NFRP)The Department of Defense fiscal year 2009 Neurofibromatosis Research Program (NFRP) has released all program announcements related to the fiscal year 2009 Appropriation of $10 million. The following funding opportunities are open to all levels of PhD or MD investigators and clinicians interested in neurofibromatosis research funding: Clinical Trial Award Investigator-Initiated Research Award Exploration-Hypothesis Development Award New Investigator Award Postdoctoral Traineeship Award FUNDING OPPORTUNITY– Dana Foundation Program in Neuroimmunology of Brain Infections and CancersCWRU SOM has been invited to nominate ONE applicant for the Dana Foundation Program in Neuroimmunology of Brain Infections and Cancers. The Neuroimmunology Program was redesigned to focus on brain infections and cancers. The Foundation is inviting studies of 1) immune-based therapies for primary brain tumors and for metastases to the brain of other cancers; 2) immune responses to infections in the brain including but not limited to viral encephalitis, meningitis, cerebral malaria, and prion diseases; and 3) how immune functions are carried out and modified in the brain. The program focuses on clinical studies in humans or human tissues. Animal studies that are directly relevant to human disease but not ready for application to studies of humans or human tissues will also be considered. This award is open to faculty tenure track researchers early in their career at the assistant professor level or early in their associate professor career. Established researchers pioneering efforts in brain infections and cancers are also eligible to apply. Postdoctoral fellows are not eligible. Projects involving collaborations with NIH intramural researchers or industry scientists are acceptable. Proposals for research that can be supported through clinical income should not be submitted. Internal Deadline: March 2 For more information, please click here. Please contact Richard J. Sohn, PhD, Richard.Sohn@case.edu., (216)368-1158 with any questions. FUNDING OPPORTUNITY– James S. McDonnell FoundationThe Foundation offers Collaborative Activity Awards to initiate interdisciplinary discussions on problems or issues, to help launch interdisciplinary research networks, or to fund communities of researchers/practitioners dedicated to developing new methods, tools, and applications of basic research to applied problems. In each case the focus of the collaborative activity must meet the program guidelines for one of the following program areas: Applications are continuously accepted for these awards. For more information, please click here. |
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIESKomen/ASCO Medical Student Rotation |
NIH Bulletin – Notices and Funding OpportunitiesCorrelative Studies with Specimens from Multi-Site Trials (R01) (PA-08-134) In Utero Exposure to Bioactive Food Components and Mammary Cancer Risk (R01) (PA-08-140) Improving Diet and Physical Activity Assessment (R21) (PAR-06-103) Allowable Salary Levels on Career Awards Supported by the National Cancer Institute (NOT-CA-09-013) New Technologies for Liver Disease STTR(R41/R42) (PA-09-094) New Technologies for Liver Disease SBIR(R43/R44) (PA-09-095) |
|
| Produced by: Gillian Irwin 11100 Euclid Avenue, Wearn 152 Cleveland, Ohio 44106-5065 216-844-8317 phone 216-844-7832 fax gillian.irwin@case.edu Janice Hassinger 11100 Euclid Avenue, Wearn 149 Cleveland, Ohio 44106-5065 216-844-1862 phone 216-844-7832 fax janice.hassinger@uhhospitals.org |
HELP US HELP YOU!If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades! Send items to gillian.irwin@case.edu. |
| If you have trouble viewing this page, click here to view the newsletter online on our website. | |